Becton Dickinson beats quarterly estimates on strength in drug-delivery devices, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand for non-essential surgical procedures, especially among older patients. On an adjusted basis, New Jersey-based Becton expects to earn between $14.25 and $14.60 per share in fiscal year 2025, the mid-point of which is above analysts’ estimate of $14.34, according to data compiled by LSEG., Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand for non-essential surgical procedures, especially among older patients. On an adjusted basis, New Jersey-based Becton expects to earn between $14.25 and $14.60 per share in fiscal year 2025, the mid-point of which is above analysts’ estimate of $14.34, according to data compiled by LSEG., , Read More